Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine Open · 2026 · 4 · 104493
DOI: 10.1016/j.gimo.2026.104493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2026. Verfasst von Marek Svoboda und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Svoboda, M., Tan, Q. K., & Lee, C. (2026). Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 4, 104493. https://doi.org/10.1016/j.gimo.2026.104493
Vancouver
Svoboda M, Tan QK, Lee C. Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2026;4:104493. doi:10.1016/j.gimo.2026.104493
BibTeX
@article{Svoboda2026,
author = {Svoboda, Marek and Tan, Queenie K.-G. and Lee, Chung},
title = {Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)},
journal = {Genetics in Medicine Open},
year = {2026},
volume = {4},
pages = {104493},
doi = {10.1016/j.gimo.2026.104493}
}
EUVIMED